Neurosciences articles for National Institutes of Health (NIH), United States of America (USA)

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 43

Article ‘Count’ for Neurosciences.

Journal Count Share
1 0.10
BLOC1S1 variants cause lysosomal and autophagic defects resulting in a hypomyelinating leukodystrophy with epileptic encephalopathy 0.10
5 0.74
Primary Lateral Sclerosis Natural History Study: Primary Lateral Sclerosis Functional Rating Scale and Other Outcomes Assessment 0.03
Individualized Atrophy‐Based Prediction of Dementia Progression in Familial Frontotemporal Lobar Degeneration With Bayesian Linear Mixed‐Effects Modeling 0.02
Disruption of the Blood–Brain Barrier Predicts Progression of Cerebral Small Vessel Disease White Matter Hyperintensities 0.40
From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple Sclerosis 0.27
scpMarkVCID2/scp Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline Characteristics 0.02
2 0.24
Neuronal titration of Snca via enhancer disruption mitigates disease onset in a Parkinson's disease mouse model 0.17
Inhibition of GluN2B-containing N-methyl-D-aspartate receptors by radiprodil 0.07
1 0.11
A cell type-specific mechanism driving the rapid antidepressant effects of transcranial magnetic stimulation 0.11
2 0.09
Pathogenic variants in BORCS5 Cause a Spectrum of Neurodevelopmental and Neurodegenerative Disorders with Lysosomal Dysfunction 0.05
Sensory neuron–expressed FGF13 controls nociceptive signaling in diabetic neuropathy models 0.04
1 0.05
Amyloidosis of bridging veins is a pathologic feature of Alzheimer’s disease 0.05
2 2.00
Cerebral Venous Thrombosis in Previously Healthy Patients with Cryptococcal Meningitis 1.00
Adrenal Corticosteroids and Increased Intracranial Pressure in Nonimmunocompromised Patients With Cryptococcal Meningitis 1.00
1 0.06
Expression and Localization of NMDA Receptor GluN2 Subunits in Dorsal Horn Pain Circuits across Sex, Species, and Late Postnatal Development 0.06
1 0.11
Design of Tau Aggregation Inhibitors Using Iterative Machine Learning and a Polymorph-Specific Brain-Seeded Fibril Amplification Assay 0.11
1 0.33
Postmortem tissue biomarkers of menopausal transition 0.33
4 1.71
Highly dynamic dural sinuses support meningeal immunity 0.85
Astrocytes enable amygdala neural representations supporting memory 0.68
Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis 0.11
SLC45A4 is a pain gene encoding a neuronal polyamine transporter 0.08
1 0.12
ALDH2-mediated GABA biosynthesis regulates hippocampal LTP and learning adaptability 0.12
9 2.77
Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality 0.03
Descending inhibitory rostral ventromedial medulla neurons cause widespread antinociception and contribute to the pain-inhibits-pain phenomenon 0.10
A reversible allosteric inhibitor of GlyT2 for neuropathic pain without on-target side effects 0.19
Longitudinal proteomic profiling of cerebrospinal fluid in untreated multiple sclerosis defines evolving disease biology 0.80
Structural basis of vilazodone dual binding mode to the serotonin transporter 0.25
Spatially-restricted inflammation-induced senescent-like glia in multiple sclerosis and patient-derived organoids 0.19
14-3-3 binding maintains the Parkinson’s associated kinase LRRK2 in an inactive state 1.00
Somatostatin-expressing interneurons induce early NO-driven and late specific astrocyte-mediated vasodilation 0.17
Variable and interactive effects of Sex, APOE ε4 and TREM2 on the deposition of tau in entorhinal and neocortical regions 0.04
1 0.01
Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis 0.01
1 0.58
A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis 0.58
2 0.98
Oxidized phosphatidylcholines deposition drives chronic neurodegeneration in a mouse model of progressive multiple sclerosis via IL-1β signaling 0.11
Differential synaptic depression mediates the therapeutic effect of deep brain stimulation 0.88
3 0.58
High-affinity, structure-validated and selective macrocyclic peptide tools for chemical biology studies of Huntingtin 0.11
Predicted molecules followed by experimental validation for protecting human neurons from oxidative stress–induced cytotoxicity 0.40
Dural ectopic lymphatic structures accumulate during aging and exhibit dysregulation in neurodegenerative diseases 0.07
1 0.04
Luminal surface proteome of the brain vasculature uncovers blood-brain barrier regulators 0.04
2 0.64
DKK3-LRP1 complex and a chemical inhibitor regulate Aβ clearance in models of Alzheimer’s disease 0.14
G proteins of the G12 family expressed by POMC neurons regulate key metabolic functions 0.50
1 0.42
Risk markers for sudden unexpected death in epilepsy: an observational, prospective, multicentre cohort study 0.42
1 0.11
Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study 0.11

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.